Piper Jaffray Cuts Price Target on Genomic Health (GHDX) After 4Q Reports In-Line with Preliminary Results
Go back to Piper Jaffray Cuts Price Target on Genomic Health (GHDX) After 4Q Reports In-Line with Preliminary Results| Genomic Health, Inc. (NASDAQ: GHDX) | Delayed: 63.44 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.44 | 52 Week High | $35.79 | |||
| Open | $12.85 | 52 Week Low | $22.00 | |||
| Day High | $63.44 | P/E | N/A | |||
| Day Low | $63.44 | EPS | $-0.42 | |||
| Volume | 32,882 | |||||
